Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
40%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
25%
ALSO IN THNR
THNR
19
HOLDINGS
33%
ALSO IN PPH
SECTOR DRIFT (PPH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.5% | 13.1% | 13.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 7.4% | 12.3% | 7.4% |
|
MERCK & CO. INC. | 7.4% | 4.9% | 4.9% |
|
PFIZER INC | 4.8% | 4.9% | 4.8% |
|
ABBVIE INC | 4.7% | 5.1% | 4.7% |
PPH Overweight Relative to THNR
 |
NOVARTIS AG-ADR | 9.8% |
|
ELI LILLY & CO | 7.4% |
|
MCKESSON CORP | 4.8% |
|
JOHNSON & JOHNSON | 4.8% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.7% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
|
ZOETIS INC | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.0% |
|
CENCORA INC | 3.8% |
|
MERCK & CO. INC. | 2.5% |
PPH Underweight Relative to THNR
|
AMGEN INC | -6.9% |
|
REGENERON PHARMACEUTICALS | -6.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -6.6% |
|
ROCHE HOLDING LTD | -5.3% |
|
NOVO-NORDISK A/S-SPONS ADR | -4.9% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.7% |
 |
INNOVENT BIOLOGICS, INC. | -4.6% |
|
SHIONOGI & CO LTD | -4.4% |
 |
CHINA PHARMACEUTICAL GROUP | -4.2% |
|
ZEALAND PHARMA A/S | -3.0% |